Samuel Agresta insider trades

Open-market stock purchases and sales by Samuel Agresta, Chief Medical Officer at OnKure Therapeutics, Inc, from SEC Form 4 filings since Aug 6, 2018.

Recent trades

DateStockTradeValue
Aug 7, 2026OKUR OnKure Therapeutics, IncBought (not open market)—
Aug 7, 2026OKUR OnKure Therapeutics, IncSold (not open market)$260K
Aug 7, 2026OKUR OnKure Therapeutics, IncBought (not open market)$77K
Aug 7, 2026OKUR OnKure Therapeutics, IncSold (not open market)$2.4M
Aug 7, 2026OKUR OnKure Therapeutics, IncBought (not open market)$544K
Apr 1, 2026OKUR OnKure Therapeutics, IncBought (not open market)—

Companies traded

  • OKUR OnKure Therapeutics, Inc: other filings, last Aug 7, 2026
  • FHTX Foghorn Therapeutics Inc: 1 sale, last Aug 16, 2023
  • INFI Infinity Pharmaceuticals, Inc: other filings, last Jun 16, 2022

Get free alerts when Samuel Agresta files a new trade →